secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001140361-25-006423
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech raises $11M in registered direct offering; warrants could add $11M
------------------------------------------------------------------------------

- Gross proceeds of ~$11M upfront from sale of 7.33M shares and warrants; warrants exercisable at $1.50/share for 5 years.
- Up to an additional $11M if all warrants are exercised for cash.
- Directors participated at $1.66/unit; institutional investors at $1.50/unit.
- Net proceeds ~$10.05M intended for R&D and general corporate purposes.
- Closing expected Feb 28, 2025; insiders subject to 60-day lock-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125006423/0001140361-25-006423-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125006423/ny20044490x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-006423

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer